The S&P 500 is up about 1 percent through the first six months of 2018, but some of its component stocks have had a rough year. Here’s a look at the 10 worst-performing stocks in the S&P 500 index year-to-date.
L Brands Inc LB
Victoria’s Secret parent L Brands has consistently disappointed with its sales numbers and guidance this year, and the stock is down 38 percent, more than any other S&P 500 component.
2. DENTSPLY SIRONA Inc XRAY
Dental equipment maker Dentsply Sirona hasn’t given its investors much reason to smile this year, with the stock down 34 percent in 2018.
3. Unum Group UNM
A rising interest-adjusted loss ratio in its long-term care business has spooked investors and sent Unum stock down 32 percent year-to-date.
4. Brighthouse Financial Inc BHF
Not even big buying from David Einhorn could help support the struggling life insurance stock, which is down 32 percent this year.
5. Incyte Corporation INCY
Much of Incyte’s 30-percent 2018 decline came in April, when the company reported a failed Phase III melanoma treatment study.
6. DISH Network Corp DISH
DISH stock tanked in May when the company shot down speculation that it would be partnering with a TV network anytime soon, and the stock is now down 29.6 percent in 2018.
7. Symantec Corporation SYMC
Issuing disappointing guidance and disclosing an internal investigation by the audit committee isn't a winning recipe for a stock like Symantec, which is down 28 percent this year.
8. Invesco Ltd. IVZ
Invesco continues to struggle with investors withdrawing cash from active funds, and the stock has fallen 27.2 percent this year.
9. Goodyear Tire & Rubber Co GT
Goodyear stock can’t seem to get any market traction this year, and a disappointing Q4 earnings report didn’t help, sending the stock down 26.8 percent year-to-date.
10. Albemarle Corporation ALB
Albermarle was a high-flyer in 2017, but competitors have flooded the market with lithium in 2018 and Albermarle stock is down 26 percent.
Related Links:
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.